New Hope for Patients with Cancer
Cancer is relentless. A diagnosis can be devastating because cancer never rests. That is why we are excited to announce the proposed acquisition of Seagen. We plan to combine our expertise with Seagen’s and deliver a powerful cancer-fighting technology called antibody–drug conjugates (ADCs) to the world. Watch to learn more about the potential of ADCs and how this proposed acquisition could help us transform the future of cancer care.
Видео New Hope for Patients with Cancer канала Pfizer
Видео New Hope for Patients with Cancer канала Pfizer
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Pfizer Big Game Commercial 2024 – Here’s to ScienceWhat is key to achieving a long-term sustainable biosimilars market?Rohini’s Story | MigraineThe Role Taste Plays in Pediatric Drug DesignLearn About the Threat Counterfeit Medicines Pose to Patients WorldwidePfizer's Environmental, Social and Governance StrategyPfizer Colleague Resource GroupsClinical Trials Day 2023: A Tribute to What’s Possible, TogetherFreeman’s Story | Multiple MyelomaHow Pfizer Delivers Breakthroughs to Patients FasterEnsuring Equity Throughout Every Step of the Research and Development ProcessGetting #COVID19 does not make a person immune to the virus that causes COVID-19Symptom Severity of COVID-19Reasons to Care about Bladder CancerKnow Plan Go if You’re at High Risk for Severe COVID-19How are Medicines Discovered & Developed?Reflections of Alopecia Areata: You Asked, We AnsweredClosing the Health Equity Gap: An Accord for a Healthier WorldFrom Tick Bite to Tick-Borne Encephalitis (TBE) – Our StorySickle Cell Disease: Patient Video